DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Ahrens M, Escudier B, Boleti E. et al.
A randomized phase II study of nivolumab plus ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST).
Journal of Clinical Oncology 2020;
DOI: 10.1200/JCO.2020.38.15_suppl.TPS5103.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.